CTLA4 and melanoma: Lim et al. found that 11 cytokines were significantly upregulated in patients with severe immune-related toxicities at baseline and early during treatment in patients with advanced melanoma treated with combination anti-CTLA-4 and anti-PD-1 immunotherapy31.